Information  X 
Enter a valid email address

Dechra Pharma PLC Ord 1P (DPH)

Related News

12-Feb-2019 01:00 PM

Broker Forecast - HSBC issues a broker note on Dechra Pharmaceuticals PLC

HSBC today initiates coverage of Dechra Pharmaceuticals PLC (LON:DPH) with a buy investment rating and price target of 2770p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
14-Jan-2019 07:35 AM

Dechra Pharmaceuticals first-half performance meets expectations

Dechra Pharmaceuticals, which supplies drugs for animals, said trading in the first half of the year was in line with its expectations amid double-digit percentage growth in both its European and North American divisions. For the half year reporting peri
23-Nov-2018 11:00 AM

Broker Forecast - RBC Capital Markets issues a broker note on Dechra Pharmaceuticals PLC

RBC Capital Markets today reaffirms its sector performer investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and cut its price target to 2100p (from 2400p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine
19-Oct-2018 07:40 AM

Dechra Q1 performance in line; acquires Venco for £37.8m

Dechra Pharmaceuticals said it was 'confident' in delivering on full-year guidance after fiscal first-quarter performance was in line with management's expectations, led by growth in both EU and North American pharmaceuticals. The company
03-Sep-2018 10:10 AM

Broker Forecast - Numis issues a broker note on Dechra Pharmaceuticals PLC

Numis today downgrades its investment rating on Dechra Pharmaceuticals PLC (LON:DPH) to hold (from add). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
10-Jul-2018 11:10 AM

Broker Forecast - Numis issues a broker note on Dechra Pharmaceuticals PLC

Numis today reaffirms its add investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and raised its price target to 2950p (from 2640p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
10-Jul-2018 07:47 AM

Dechra Pharmaceuticals expects annual performance to meet expectations

Dechra Pharmaceuticals said Tuesday trading in the year through June had been 'strong' and in line with management expectations. For the 12 months to 30 June, reported group revenue is expected to increase by about 14% at constant exchange rat
26-Feb-2018 10:08 AM

Dechra Pharmaceuticals revenue grows 11.2% amid strong performance in North America

Dechra Pharmaceuticals reported revenue of £194.1m for the six months ended 31 December 2017, up 11.2% at constant exchange rate (CER) 12.5% on actual exchange rate (AER). The firm declared an interim dividend of 7.33 pence per share, which repres
02-Feb-2018 12:40 PM

Broker Forecast - Numis issues a broker note on Dechra Pharmaceuticals PLC

Numis today reaffirms its add investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and set its price target at 2640p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
30-Jan-2018 09:10 AM

Broker Forecast - Jefferies International issues a broker note on Dechra Pharmaceuticals PLC

Jefferies International today upgrades its investment rating on Dechra Pharmaceuticals PLC (LON:DPH) to buy (from hold) and raised its price target to 2631p (from 2221p). Story provided by StockMarketWire.com...
17-Jan-2018 01:50 PM

Broker Forecast - Jefferies International issues a broker note on Dechra Pharmaceuticals PLC

Jefferies International today reaffirms its hold investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and set its price target at 2221p. Story provided by StockMarketWire.com...
09-Jan-2018 08:20 AM

Dechra sees double-digit revenue growth

Dechra Pharmaceuticals said trading in the period from the start of July to the end of December was strong and in line with management expectations. Reported group revenue increased by around 10.5% at constant exchange rates and at around 11.5% at actua
20-Oct-2017 07:06 AM

Dechra sees continued growth across all markets

Dechra Pharmaceuticals' performance in the first quarter was in line with management expectations, with continued growth across all of its markets, shareholders at today's annual general meeting will be told. Dechra said that no other new trad
08-Sep-2017 08:40 AM

Broker Forecast - Cantor Fitzgerald issues a broker note on Dechra Pharmaceuticals PLC

Cantor Fitzgerald today reaffirms its buy investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and raised its price target to 2200p (from 1500p). Story provided by StockMarketWire.com...
05-Sep-2017 11:00 AM

Broker Forecast - Jefferies International issues a broker note on Dechra Pharmaceuticals PLC

Jefferies International today reaffirms its hold investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and raised its price target to 1868p (from 1565p). Story provided by StockMarketWire.com...
06-Jul-2017 08:17 AM

Dechra growth driven by core portfolio

Dechra Pharmaceuticals said trading in the year ended 30 June was strong and in line with management expectations, with a good performance from the core business complemented by the successful integration and performance of acquisitions. Reported grou
04-Apr-2017 04:10 PM

Broker Forecast - Numis issues a broker note on Dechra Pharmaceuticals PLC

Numis today reaffirms its add investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and raised its price target to 1890p (from 1700p). Story provided by StockMarketWire.com...
04-Apr-2017 12:20 PM

Broker Forecast - Stifel issues a broker note on Dechra Pharmaceuticals PLC

Stifel today reaffirms its hold investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and raised its price target to 1550p (from 1440p). Story provided by StockMarketWire.com...
14-Mar-2017 10:40 AM

Broker Forecast - RBC Capital Markets issues a broker note on Dechra Pharmaceuticals PLC

RBC Capital Markets today reaffirms its outperform investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and raised its price target to 1890p (from 1630p). Story provided by StockMarketWire.com...
01-Mar-2017 10:40 AM

Broker Forecast - Jefferies International issues a broker note on Dechra Pharmaceuticals PLC

Jefferies International today reaffirms its hold investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and raised its price target to 1565p (from 1320p). Story provided by StockMarketWire.com...
27-Feb-2017 09:24 AM

Dechra underlying operating profits up

Dechra Pharmaceuticals posts underlying operating profits of £38.6m for the six months to the end of December - up 47.1% at actual exchange rates and 28.6% at constant currencies. Revenues of £172.6m were ip 55.9% at actual exchange rates and
17-Jan-2017 07:58 AM

Dechra revenues rise

Dechra Pharmaceuticals says reported group revenue for the six months to the end of December increased by approximately 34% at constant exchange rate (56% at actual exchange rate). Core group revenue growth, excluding the benefit from acquisitions, was
21-Oct-2016 07:18 AM

Dechra on track

Dechra Pharmaceuticals' performance in the first quarter was in line with management expectations with all of the recent acquisitions performing well, shareholders at the annual general meeting today will be told. A statement issued ahead of the mee
14-Oct-2016 09:15 AM

Dechra Pharma completes Apex Lab acquisition

Dechra Pharmaceuticals said the acquisition of the business and assets of Apex Laboratories Pty Ltd has now completed. At 9:15am: (LON:DPH) Dechra Pharmaceuticals PLC share price was +9.5p at 1379.5p Story provided by StockMarketWire.com...
27-Sep-2016 11:00 AM

Broker Forecast - Cantor Fitzgerald issues a broker note on Dechra Pharmaceuticals PLC

Cantor Fitzgerald today reaffirms its buy investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and set its price target at 1500p. Story provided by StockMarketWire.com...

a d v e r t i s e m e n t